Trimetazidine–Profen Hybrid Molecules: Synthesis, Chemical Characterization, and Biological Evaluation of Their Racemates
<b>Background:</b> Trimetazidine is a clinically established cardioprotective agent with anti-ischemic and antioxidant properties, widely used in the management of coronary artery disease. Combining its metabolic and cytoprotective effects with the potent anti-inflammatory activity of profens presen...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2025-08-01
|
| Reeks: | Pharmaceuticals |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1424-8247/18/9/1251 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
